Deepa Jewellers IPO
₹168 – ₹168 · Issue Size ₹459.72 CrIPO Overview
IPO Timeline
Listing Performance
Management & Promoters
Peer Comparison
| Company | P/E | EPS |
|---|---|---|
| Deepa Jewellers IPO | — | — |
| Exchange Management (Non-debt Instruments) Amendment Rules w | 22.0x | — |
Pre-IPO Financials
| Period | Revenue (Cr) | PAT (Cr) | Net Worth (Cr) | Total Assets (Cr) |
|---|---|---|---|---|
| September 2025 | ₹812.19 Cr | ₹48.62 Cr | — | ₹299.75 Cr |
| March 2025 | ₹1,397.01 Cr | ₹40.58 Cr | — | ₹217.67 Cr |
| March 2024 | ₹1,024.57 Cr | ₹24.35 Cr | — | ₹174.64 Cr |
| March 2023 | ₹921.26 Cr | ₹22.02 Cr | — | ₹152.81 Cr |
About
Q-Line Biotech Ltd. (QBL) is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs since 2013 directly or through its distributor/s majorly to diagnostic service providers, hospitals and medica
Key Regulations and Policies in India", "History and Certain Corporate Matters", "Basis for the Offer Price" "Restriction on Foreign Ownership of Indian Securities", "Restated Financial Information", "Other Regulatory and Statutory Disclosures" and "Outstanding Litigation and Material Developments", on pages 398, 120, 125, 221, 227, 111, 396, 257, 354 and 346 will have the meaning ascribed to such terms in those respective sections. General terms Term Description our Company/ the Company/ the Issuer Deepa Jewellers Limited, a public limited company incorporated under the Companies Act, 201
| Exchange | NSE |
| Issue Type | mainboard |
| Face Value | ₹2 per share |
Documents
rupiya.io is for research and education only. IPO data is sourced from public disclosures (DRHP/RHP). Not investment advice. Validate with SEBI-regulated disclosures before acting.